Pixium Vision S.A.

$1.50+0.00%(+$0.00)
TickerSpark Score
33/100
Poor
20
Valuation
20
Profitability
50
Growth
44
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXMVF research report →

52-Week Range100% of range
Low $0.03
Current $1.50
High $1.50

Companywww.pixium-vision.com

Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC.

CEO
Lloyd Diamond
IPO
2021
Employees
40
HQ
Paris, FR

Price Chart

+0.00% · this period
$1.50$1.50$1.50Apr 17Oct 16Apr 17

Valuation

Market Cap
$4.62M
P/E
-1.92
P/S
579.42
P/B
-6.46
EV/EBITDA
-0.40
Div Yield
0.00%

Profitability

Gross Margin
-40274.55%
Op Margin
-597250.00%
Net Margin
-478473.75%
ROE
-645.71%
ROIC
-133.17%

Growth & Income

Revenue
$2.00K · -99.77%
Net Income
$-9,569,475 · 17.49%
EPS
$-0.20 · 16.67%
Op Income
$-11,945,000
FCF YoY
-28.65%

Performance & Tape

52W High
$1.50
52W Low
$0.03
50D MA
$1.50
200D MA
$1.50
Beta
0.97
Avg Volume
458

Get TickerSpark's AI analysis on PXMVF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our PXMVF Coverage

We haven't published any research on PXMVF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate PXMVF Report →

Similar Companies